Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

867: Closed Automation Enables Quick Fill-Finish of Large-Scale T Cell Therapy While Maintaining Consistency and Quality of the Final Product

Disclosures:   M. Park: 1; Commercial Interest i.e. Company X; Charles river laboratories. 1; What was received? i.e. Honorarium; Salary. 1; For what role? i.e. Speaker; Employment.

Related Abstract

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.